Cite

HARVARD Citation

    Rutherford, O. et al. (2020). Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study. European heart journal. 6 (2), pp. 75-85. [Online]. 
  
Back to record